Dr Reddys Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹8,099.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.33 per cent from ₹7,546.40 crore. This corresponds to a year-on-year *(YoY) decline of 5.51 per cent.
Operating Profit
Operating Profit stands at ₹861.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.59 per cent from ₹640.00 crore. This corresponds to a year-on-year *(YoY) decline of 60.37 per cent.
PBDT
PBDT stands at ₹1,089.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.01 per cent from ₹756.80 crore. This corresponds to a year-on-year *(YoY) decline of 54.23 per cent.
Profit Before Tax
Profit Before Tax stands at ₹553.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 177.07 per cent from ₹199.70 crore. This corresponds to a year-on-year *(YoY) decline of 70.96 per cent.
Net Profit
Net Profit stands at ₹435.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 96.84 per cent from ₹221.30 crore. This represents a 69.10 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -0.33% | -0.25% | -1.74% | -9.72% | -6.16% | -4.89% |
| Cipla | -0.75% | -0.82% | 0.59% | 1.64% | 7.48% | -7.31% |
| Zydus Lifesci. | -2.81% | -3.39% | -0.58% | 15.01% | 25.27% | 15.55% |
| Lupin | -1.15% | -1.89% | -9.82% | -0.80% | 0.39% | 13.48% |
| Mankind Pharma | 0.08% | -0.21% | -5.69% | -3.06% | 16.62% | -2.02% |
| Laurus Labs | -1.42% | -2.42% | 16.40% | 36.76% | 74.90% | 109.74% |
| Aurobindo Pharma | 0.08% | 0.97% | 6.24% | 10.41% | 42.96% | 52.11% |
Company Info
Company Information
Chairman & Exec. Director : Satish Reddy
Co-Chairman & Managing Director : G V Prasad
Independent Non Exe. Director : Leo Puri
Independent Non Exe. Director : Shikha Sharma
Independent Non Exe. Director : KODUMUDI PRANATHARTHIHARAN KRISHNAN
Independent Non Exe. Director : Pennv Wan
Independent Non Exe. Director : Arun M. Kumar
Independent Non Exe. Director : Claudio Albrecht
Independent Non Exe. Director : ALPNA HANSRAJ SETH
Independent Non Exe. Director : Sanjiv Mehta
Independent Non Exe. Director : Srikanth Ramakrishna Velamakanni
CS / CO / Head - CSR : K Randhir Singh